FDA Investigator Dennis E Guilfoyle, PhD
Dennis E Guilfoyle, PhD has conducted inspections on 10 sites in 1 countries as of 02 Oct 2012. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
10
Last Inspection Date:
02 Oct 2012
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Dennis E Guilfoyle, PhD:
Alberto A Viciedo,
Althea A Williams,
Amatul H Marium,
Amber D Brodas,
Amy M Cramer,
Andrace L Deyampert,
Andrea D Swingle,
Ann L Demarco,
Antonina Aydanian,
Barbara J Maulfair,
Bei Y He,
Benjamin J Smith,
Bijoy Panicker,
Byungja E Marciante,
Candace Y Gomez Broughton,
Charisse K Green,
Charles I Ann,
Charles Jewell,
Charles L Zhou,
Constantin Y Philopoulos,
Corrine M Carter,
Daniel J Grabicki,
David A Paterson,
Dawn L Wydner,
Debara R Reese,
Debara Reese,
Deborah B Nixon,
Demitria J Argiropoulos,
Demitria J Xiradakis,
Denise L Burosh,
Diane L Raccasi,
Dina A Tallman,
Donald C Obenhuber, PhD,
Dr. Robert C Horan, MD,
Edmund F Mrak, Jr,
Emest F Bizjak,
Emily J Orban,
Eric J Cunningham,
Eric Rothschild,
Frank J Marciniak,
Frank Verni,
Freyja V Lynn,
Gary J Lehr,
Gobiga Vanniyasingam,
Guerlain Ulysse,
Helen B Ricalde,
Jacqueline Mdiaz Albertini,
Jacqueline S Warner,
James A Liubicich,
James C Maclaughlin,
James M Mason,
Jean Blackston Hill,
Jean M Kelahan,
Jeffrey A Sommers,
Jeffrey D Meng,
Jennifer A Kemp,
Jennifer L Bridgewater,
John A Podsadowski,
Joseph A Piechocki,
Joseph F Mcginnis, RPh,
Joseph R Strelnik,
Juanita P Versace,
Karen E D'orazio,
Karen L Kosar,
Karen M Montgomery (KMM),
Kazi Rafiquzzaman,
Kenneth H Williams,
Kevin A Gonzalez,
Kinh Q Mac,
Kristen D Evans,
Kristina L Conroy,
L'oreal F Walker,
Larry K Austin,
Lata C Mathew, PhD,
Lauren Iacono Connors, PhD,
Lawrence W Farina,
Leigh Anne Myers,
Li Li,
Linda M Sacco,
Lisa M Bellows,
Loretta Nemchik,
Lori Peters,
Luella J Rossi,
Maria Joselopez Barragan, PhD,
Marjorie A Shapiro, PhD,
Marsha W Major,
Martha T Olone,
Mary Davis Lopez,
Mate Tolnay,
Matthew A Spataro,
Matthew W Kyle,
Meisha R Sampson,
Meisha Waters,
Melina Lrodriguez Upton,
Melissa A Zuppe,
Mercy Oyugi,
Michael A Charles,
Michael Levin,
Michael O Idowu,
Michael Shanks, MS,
Michele L Forster, PhD,
Miguel Gmanzano Maldonado,
Mihaly S Ligmond,
Milan S Blake,
Mindy M Chou,
Montgomery Montgomery, Karen M,
Muna Algharibeh,
Myra K Casey,
Nailing Zhang,
Nancy T Waites,
Neali H Lucas,
Nicholas A Violand,
Nicholas C Mendiola,
Omotunde O Osunsanmi,
Parul M Patel,
Patricia A Cochran,
Patricia F Hughes, PhD,
Patricia H Dlugosz,
Patrick B Cummings,
Patsy J Domingo,
Paul Mouris,
Paula A Trost,
Perry T Nichols,
Peter Abel,
Philip F Istafanos, DMV, MS,
Phillip M Pontikos,
Prabhu P Raju,
Qiao Y Bobo,
Rafeeq A Habeeb,
Raihan A Chowdhury,
Ramon A Hernandez,
Rashmi Rawat, PhD,
Raymond T Oji,
Rebecca E Dombrowski,
Richard W Thornton,
Robert C Steyert,
Robert D Tollefsen,
Robert G Ruff,
Robert J Ham,
Robert J Maffei,
Robert Jennings,
Robert M Barbosa,
Russ E Davis,
Sandra A Boyd,
Sarah B Tanksley,
Scott E Norris,
Shari L Kahn,
Shirley S Wen,
Simone E Pitts,
Sinai I Davis,
Sony Mathews,
Susan F Laska, MS,
Susan M Jackson,
Susan P Bruederle,
Suyang Qin,
Tania E Vizcaino,
Tara G Bizjak,
Tara R Gooen,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Tina M Pawlowski,
Tina S Roecklein,
Tonia F Bernard,
Valentino Fiorella,
Valerie A Potopsingh,
Wayne E Seifert,
William D Tingley,
William M Rennells,
Yangmin Ning,
Yumi J Hiramine,
Yvins Dezan
Dennis E Guilfoyle, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| January, 2002 | FDA 483 | Eli Lilly and Company - Form 483, 2002-01-11 |
| November, 2012 | FDA 483 | Pharmaceutical Innovations, Inc. - Form 483, 2012-11-06 |
| December, 2008 | FDA 483 Response | American Regent, Inc. - Form 483R, 2009-01-16 |
| December, 2008 | FDA 483 | American Regent, Inc. - Form 483, 2008-12-16 |
| January, 2002 | FDA 483 Response | Eli Lilly and Company - Form 483R, 2002-01-25 |
| October, 2003 | FDA 483 Response | Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483R, 2003-12-17 |
| January, 2002 | EIR | Eli Lilly and Company - EIR, 2002-01-11 |
| October, 2003 | FDA 483 | Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483, 2003-10-28 |
| December, 2008 | EIR | American Regent, Inc. - EIR, 2008-12-16 |
| October, 2003 | EIR | Wyeth Pharmaceutical Division of Wyeth Holdings LLC - EIR, 2003-10-28 |
| June, 2009 | FDA 483 | Howmedica Osteonics Corp. - Form 483, 2009-06-19 |
| January, 2002 | EIR | Eli Lilly and Company - EIR, 2002-01-14 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more